Arecor Therapeutics plc

AREC.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-£3-£6-£5-£4
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£0£0£0
Change in WC£1-£3£0£1
Other Non-Cash£0£3-£0£1
Operating Cash Flow-£1-£5-£4-£1
Investing Activities
PP&E Inv.-£0-£0-£0-£0
Net Acquisitions£0£0£0£0
Inv. Purchases-£0£0£0£0
Inv. Sales/Matur.£0-£0£2-£0
Other Inv. Act.£0£0£0£0
Investing Cash Flow£0-£0£2£0
Financing Activities
Debt Repay.£0-£0£0£0
Stock Issued£0£6£0£0
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.-£0-£0-£0-£0
Financing Cash Flow-£0£6-£0-£0
Forex Effect-£0-£0-£0-£0
Net Chg. in Cash-£1£1-£3-£2
Supplemental Information
Beg. Cash£3£3£5£7
End Cash£2£3£3£5
Free Cash Flow-£1-£5-£4-£1
Arecor Therapeutics plc (AREC.L) Financial Statements & Key Stats | AlphaPilot